Fusobacterium Nucleatum at Colorectal Cancer Sites
Presence of Fusobacterium Nucleatum at Colorectal Cancer Sites - Influencing Factors and Screening Possibilities
1 other identifier
interventional
150
1 country
1
Brief Summary
Recent studies suggest an association of periodontitis with an overall increased cancer risk but also with cancer development in specific anatomic regions, such as in the colon. The gut microbiome in general and specifically Fusobacterium nucleatum have been described to likely affect colorectal cancer (CRC) development. The present project intends to evaluate the possible contribution of the oral cavity as a reservoir for dissemination of F.nucleatum to the colon. Additionally, the gut microbiome and dietary intake will be assessed as possible factors influencing colonization of CRC sites with F. nucleatum and an association of F.nucleatum colonization in the colon with parameters in the saliva and serum will be tested. One-hundred-fifty patients diagnosed with CRC will be included; after cancer diagnosis and before starting cancer treatment a periodontal examination will be done and saliva and serum samples and at the time-point of tumor resection a biopsy of the CRC sites will be collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable colorectal-cancer
Started Nov 2017
Longer than P75 for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 29, 2017
CompletedFirst Submitted
Initial submission to the registry
July 3, 2023
CompletedFirst Posted
Study publicly available on registry
July 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 14, 2023
July 1, 2023
8.1 years
July 3, 2023
July 11, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Presence of F.nucleatum in a colon cancer biopsy
dichotomous (present / absent)
At timepoint of biopsy
Interventions
biopsy of a colorectal cancer site
Eligibility Criteria
You may qualify if:
- diagnosis of colorectal cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Malmö Universitylead
- Skane University Hospitalcollaborator
Study Sites (1)
Skane University Hospital
Malmo, Sweden
Related Publications (1)
Plomp N, Bertl K, Lydrup ML, Sjoberg K, Harmsen HJM, Stavropoulos A. Does Fusobacterium in Colorectal Cancer Sites Originate From the Oral Cavity? A Pilot Study. Clin Exp Dent Res. 2024 Dec;10(6):e70016. doi: 10.1002/cre2.70016.
PMID: 39491831DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2023
First Posted
July 14, 2023
Study Start
November 29, 2017
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
July 14, 2023
Record last verified: 2023-07